缺氧:三阴性乳腺癌与各种治疗方案的联合
Nityanand Srivastava1, Salman Sadullah Usmani2, Rajasekaran Subbarayan3,4
1Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, United States.
Frontiers in oncology
|July 26, 2023
概括
三阴性乳腺癌 (TNBC) 是由于缺氧而具有侵略性和致命性的. 向缺氧诱导因子-1alpha (HIF-1α) 提供了新的治疗策略,以克服TNBC的治疗耐药性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 三阴性乳腺癌 (TNBC) 呈现出高度的攻击性,异质性,并且受到瘤缺氧的显著影响.
- 缺氧驱动TNBC中的关键途径,包括新陈代谢 (糖解),血管生成,癌症干细胞丰富和免疫逃逸,导致入侵和转移.
- 缺氧还会影响表观遗传可塑性和DNA损伤反应,通过缺氧诱导因子-1alpha (HIF-1α) 信号传递对TNBC存活率和治疗耐药性作出贡献.
研究的目的:
- 审查缺氧和HIF-1α信号在TNBC进展和治疗抵抗中的关键作用.
- 探索针对HIF-1α作为针对TNBC的治疗策略的潜力.
- 讨论目前面临的挑战和未来发展TNBCHIF-1α向治疗的前景.
主要方法:
- 对研究低氧,HIF-1α和TNBC治疗策略的综合文献综述.
- 对生物和临床观察结果的分析,将低氧与TNBC攻击性和治疗结果联系起来.
- 讨论各种治疗方案,包括化疗,放射治疗,免疫治疗,以及针对HIF-1α的新方法.
主要成果:
- 缺氧通过调节代谢,发育和生存途径显著促进TNBC的攻击性.
- HIF-1α信号传递是低氧诱导的TNBC进展,CSC丰富,免疫逃避和治疗抵抗的中心调解者.
- 向HIF-1α为开发新型治疗策略以克服TNBC耐药性提供了一个有希望的途径.
结论:
- HIF-1α是开发针对侵袭性和耐治疗性TNBC的有效疗法的关键目标.
- 针对HIF-1α和缺氧诱导信号的进一步研究对于改善患者的治疗结果至关重要.
- 针对HIF-1α的组合疗法和新型治疗方式对TNBC的管理具有重大前景.
相关概念视频
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
265
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
265
Hypoxia
1.1K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.1K


